Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
Shahnam Sharif(University Medical Center Utrecht), Hendrik M. Nathoe, Guy E.H.M. Rutten(University Medical Center Utrecht), Gert J. de Borst(Reinier de Graaf Hospital), Jan Westerink(Utrecht University), Yolanda van der Graaf(SUNY Downstate Health Sciences University), Rutger van Petersen, Ale Algra(University Medical Center Utrecht), Tim Leiner(Mayo Clinic), L. Jaap Kappelle(University Medical Center Utrecht), Frank L.J. Visseren(University Medical Center Utrecht), L.J. Kapelle(University Medical Center Utrecht), B. G. F. Dinther, Maarten J. Cramer(SUNY Downstate Health Sciences University), Diederick E. Grobbee(University Medical Center Utrecht)
Cited by 204
Related Papers
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
|Stroke|1993|12.3k
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2021|6.1k
Prognosis and prognostic research: what, why, and how?
|BMJ|2009|1.4k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k